Walgreens Boots Alliance (WBA) - Get Report CEO Stefano Pessina said there is a high bar to entry in the pharmacy market that Amazon.com (AMZN) - Get Report might not be able to overcome, CNBC reported.

Reports have stated Amazon is considering venturing into the mail-order drugs business, but Pessina said there is a "challenging market for pharmacies" that only "big players" have survived. He said there aren't a lot of new things Amazon could do.

"If you analyze this coldly, you would see this is not the best opportunity for Amazon," Pessina said. Regulatory controls, increasing margin pressure on generic drugs and consolidation have changed the industry in a way Amazon might not understand.

But Pessina made it clear he's ready to take on Amazon if the online retailer does move into his market. "At the end of the day, we could find our role in the new environment."

What's Hot On TheStreet

Happy birthday iPhone: Apple's (AAPL) - Get Report iPhone turns 10 years old today! What an amazing product Steve Jobs and his team created. But, as TheStreet's Natalie Walters points out, the next five years for Apple could be radically different. Sales could well be boosted by new, non-iPhone products such as smart glasses and autonomous car technologies. Walters also mentions that iPhone demand may peak in 2019.

Blue Apron falters: Blue Apron (APRN) - Get Report plans an initial public offering on Thursday seeking a valuation of about $2 billion. That's down significantly from a $3.2 billion valuation it had previously hoped to achieve. In the public sphere, the New York-based meal kit delivery service's IPO comes at an unsettling time, points out TheStreet's Ron Orol, as the markets begin to digest Amazon Inc.'s (AMZN) - Get Report mega $13.4 billion acquisition of Whole Foods Market Inc. (WFM) . Moreover, investors have questioned Blue Apron's business model -- it hasn't turned a profit since 2012 due to rising marketing and distribution costs.

Regulators outsmarted: With questions swirling whether its combination would get approved by regulators, Walgreens Boots Alliance (WBA) - Get Report and Rite-Aid (RAD) - Get Reportstruck a clever deal on Thursday. Walgreens will pay $5.175 billion to Rite-Aid in cash and receive 2,186 stores in return. Walgreens will also pay Rite-Aid a $325 million termination fee for its planned buyout of the company.

Walgreens will be an even bigger drug-selling beast, with more than 15,000 stores spanning 11 countries. As for Rite-Aid, it will be left with about 2,300 stores once the deal closes in six months.

Apple and Walgreens Boots Alliance are holdings in Jim Cramer's Action Alerts PLUS Charitable Trust Portfolio. Want to be alerted before Cramer buys or sells AAPL and WBA? Learn more now.

Visit here for the latest business headlines.